Search results
Results from the WOW.Com Content Network
Morepen Laboratories Limited (NSE:MOREPENLAB) shareholders might be concerned after seeing the share price drop 14% in the last quarter. But that doesn't change the fact that the returns over the ...
Morepen Laboratories Limited (NSEI:MOREPENLAB) trades with a trailing P/E of 42.2x, which is higher than the industry average of 27.2x. While MOREPENLAB might seem like a stock to avoid orRead More...
Today we will run through one way of estimating the intrinsic value of Morepen Laboratories Limited (NSE:MOREPENLAB...
Vinita D. Gupta (born 1968/1969) is an Indian businesswoman, the chief executive officer (CEO) of Lupin Limited since September 2013, [1] and the chairperson of Lupin Inc (LI), and its US subsidiary, Lupin Pharmaceuticals Inc (LPI).
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [1] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of active pharmaceutical ingredients locally produced. [1]
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
For premium support please call: 800-290-4726 more ways to reach us
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. The company went public in 1973.